Arcturus Therapeutics Holdings Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -156.6% | – | – | |
| – | +64.5% | +19.6% | +572.1% | +42.0% | +17.5% | +28.9% | +35.3% | +28.0% | +93.6% | +19.9% | -14.6% | |
| – | -42.2% | +5.7% | -13.2% | -42.0% | +57.4% | +241.3% | +327.5% | +5.9% | +13.2% | +9.6% | -33.1% | |
| – | -91.7% | +149.3% | +215.7% | -40.1% | +78.5% | +136.9% | +435.3% | – | – | – | – | |
| – | -387.4% | – | +175.0% | -115.7% | – | +32.7% | +53.8% | -138.5% | – | -381.9% | – | |
| – | +129.1% | -59.1% | +239.2% | +488.8% | -44.7% | +113.0% | +95.5% | +126.8% | -62.5% | -77.7% | -64.5% | |
| – | -502.5% | – | +112.1% | +113.8% | -103.7% | +113.0% | +95.5% | +126.8% | -62.5% | -77.7% | -64.5% | |
| – | +0.0% | -98.0% | +0.0% | -75.4% | +11,033.1% | +1,054.0% | -99.7% | – | – | – | – | |
| – | – | +199.7% | +0.0% | +74.7% | -49.9% | +842.3% | +0.0% | -110.7% | +447.3% | -100.0% | – | |
| – | +0.0% | -100.0% | +116,533.3% | +45.8% | +310.7% | +940.7% | -89.0% | -106.0% | +742.5% | – | +147.0% | |
| – | – | -199.1% | – | -31.5% | +199.2% | +1,030.2% | -123.1% | – | -310.6% | – | – | |
| – | – | – | – | – | – | – | – | – | -186.5% | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.